Anemia: Only a marker or an independent predictor of mortality in advanced heart failure?;Anemia: Apenas marcador ou preditor independente de mortalidade na insuficiência cardíaca avançada [40]

Revista Portuguesa de Cardiologia

Volumn 30, Issue 5, 2011, Pages 515-535

  Saraiva, Fátima ^a,b   Martins, Hélia ^a,b   Costa, Susana ^a,b   Franco, Fátima ^a,b   Gonçalves, Lino ^a,b   Providência, Luís A ^a,b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Advanced heart failure; Anemia; Mortality

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOLAZONE; NITRATE; SPIRONOLACTONE; WARFARIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CARDIOVASCULAR RISK; CHILD; CLINICAL STUDY; COMORBIDITY; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

EID: 79960486020     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Mann D. Management of Heart Failure Patients with Reduced Ejection Fraction. Chapter 25. In: Braunwald E, Libby P, Bonow R, Mann D, Zipes D. Braunwald's Heart Disease. Philadelphia: Saunders Elsevier, 2008;.
2. McMurray J, et al. Heart Failure. Chapter 23. In: Camm A, Lüscher T, Serruys P. The ESC Textbook of Cardiovascular Medicine. New York: Oxford University Press, 2009:835-40.
3. Lev D, Kenchaiah S, Larson MC, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347:1397-402.
4. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: 6A-13A.
5. Krumholz H, Parent E, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99-104. (Pubitemid 27027080)
6. Horwich T, Fonarow C, Hamilton M, et al. Anemia Is Associated With Worse Symptoms, Greater Impairment in Functional Capacity and a Significant Increase in Mortality in Patients With Advanced Heart Failure. J Am Coll Cardiol 2002; 39(11):1780-6. (Pubitemid 34595288)
7. Richter C, Kalenga J, Rowe B, et al. Practice patterns and outcomes in patients presenting to the emergency department with acute heart failure. Can J Cardiol 2009;25:e173-178.
8. Bajraktari G, Emini M, Shabani X, et al. Predictors of mortality in medically treated patients with congestive heart failure of nonrheumatic etiology and reduced systolic function. Eur J Int Med 2009;20:362-365.
9. Tang Y, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 2006; 113: 2454-61. (Pubitemid 43948053)
10. Maggioni AP, Opasich C, Anand I, et al. Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice. J Card Fail 2005;11:91-8. (Pubitemid 40269782)
11. Al-Ahmad A, Rand WM, Manjunath C, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38:955-62. (Pubitemid 32912694)
12. Anker SD, Sharma R, Fracis D, et al. Anemia and survival in 3044 patients with chronic heart failure in the ELITE II study [abstract]. Circulation 2002;106(Suppl):2335A.
13. Young JB, Abraham WT, Albert NM, et al. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am Heart J 2008;101:223-30.
14. Androne AS, Katz S, Lund L. Hemodilution is common in patients with advanced heart failure. Circulation 2003;107:226-9. (Pubitemid 36135215)
15. Silverberg D, Wexler D, Sheps D, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant, congestive heart failure improves cardiac and renal function and functional cardiac class and markedly reduces hospitalizations. J Am Coll Cardiol 2000; 35:1737-44. (Pubitemid 30342851)
16. Abassade P, Rabenirina F, Garcon P, et al. L'anémie dans l'insuffisance cardiaque. Ann Cardiol Ang 2009;58: 289-292.
17. Haehling S, Schefold J, Hodoscek L. Anaemia is an independent predictor of death in patients hospitalized for acute heart failure. Clin Res Cardiol 2010;99:107-13.
18. Nieminen MS, Harjola VP, Hochadel M, et al. Gender related differences in patients presenting with acute heart failure - results from EuroHeart Failure Survey II. Eur J Heart Fail 2008;10:140-8. (Pubitemid 351221390)
19. Peterson P, Magid D, Lyons E, et al. Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failure. Am Heart J 2010;159:81-9.
20. Anand IS, Kuskowski MA, Rector TS, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation 2005; 45:391-9.
21. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2008;107:223-5. (Pubitemid 36135214)
22. Anand IS. Anemia and chronic heart failure. Implications and treatment options. J Am Coll Cardiol 2008; 52:501-11.
23. George J, Patal S, Wexler D, et al. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers. Arch Int Med 2005;165:1304-9. (Pubitemid 40989597)
24. Meer P, Voors AA, Lipsic E, et al. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol 2004; 44:63-7. (Pubitemid 38968458)
25. Sharma R, Francis DP, Pitt B, et al. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the Elite II trial. Eur Heart J 2004; 25: 1021-8. (Pubitemid 38869420)
26. Tang WH, Tong W, Francis GS, et al. Evaluation and long term prognosis of new onset transient and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2008; 51:569-76.
27. O'Meara E, Clayton T, McEntegart MB, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 2006; 113:986-94. (Pubitemid 43879474)
28. Teng TH, Finn J, Hung J. Mild anemia is associated with increased all-cause mortality in heart failure. Heart, Lung and Circulation 2009;xxx:1-7.
29. Kannel WB. Epidemiology and prevention of cardiac failure: Framingham Study insights. Eur Heart J 1987; 8F:23-9.
30. Kosiborod M, Smith GL, Radford MJ, Foody JM, et al. The prognostic importance of anemia in patients with heart failure. Am J Med 2003;114:112-9. (Pubitemid 36183592)
31. Terrovitis J, Anastasiou-Nana M, Alexopoulos G, et al. Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard versus high doses of enalapril. J Heart Lung Transplant 2006;25:333-8. (Pubitemid 43290665)
32. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure. The Prospective Randomized Amlodipine Survival Evaluation (PRAISE). J Am Coll Cardiol 2003;41:1933-9. (Pubitemid 36677110)
33. Felker GM, Gattis WA, Leimberger JD, et al. Usefulness of anemia as a predictor of death and re-hospitalization in patients with decompensated heart failure. Am J Cardiol 2003; 92:625-8. (Pubitemid 37013425)
34. Datta BN, Silver MD. Cardiomegaly in chronic anemia in rats and man experimental study including ultrastructural, histometric, and stereologic observations. Lab Invest 1975; 32:503-14.
35. Olivetti G, Quaini F, Lagrasta C, et al. Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats. Am J Pathol 1992; 141:227-39.
36. Anand I, McMurray JJ, Whitmore J, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004;110:149-54. (Pubitemid 38924582)
37. Kosiborod M, Curtis JP, Wang Y, et al. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med 2005;165:2237-44. (Pubitemid 41549919)
38. Groenveld H, Januzzi J, Damman K, et al. Anemia and mortality in heart failure patients. A systematic review and meta-analysis. J Am Coll Cardiol 2008;52:818-27.
39. Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001;37:1775-80. (Pubitemid 32499958)
40. Palazzuoli A, Siverberg D, Iovine F, et al. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J 2006;152:1096e9-15.
41. Ghali JK, Anand IS, Abraham WT, et al. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation 2008;117:526-35.